People

All people involved with Variant Effect

Leadership

Executive Committee

David Adams (he/him)

David Adams is a Senior Group Leader at the Wellcome Sanger Institute with an interest in functional genomics, genetic screens, cancer models and drug discovery. He is also interested in cancer predisposition and works extensively with investigators in low and middle income countries, particularly in Latin America.

Benedetta Bolognesi (she/her)

Dr. Bolognesi is a Group Leader at the Institute for Bioengineering of Catalonia (IBEC). She trained in biophysics at the University of Cambridge and in genomics at the Center for Genomic Regulation. Her lab develops scalable assays that report both on folded and intrinsically disordered proteins, with the ultimate goal of understanding functional and pathological protein aggregation.

Doug Fowler (he/him)

Dr. Fowler is a Professor of Genome Sciences and Director of the Center for the Multiplexed Assessment of Phenotype at the University of Washington. Dr. Fowler is a leader in high-throughput, sequencing-based assays, and his lab has developed foundational technologies for interrogating the effect of human genetic variants. He is now working to understand the effects of the millions of variants found in a typical human genome.

Irene Gallego Romero (she/her)

Dr. Gallego Romero is the Head of human genomics and evolution at St. Vincent’s Institute of Medical Research. Her work focuses on genetic differences between human populations, personalized medicine, and global health equity. Irene’s lab combines functional genomics with the versatility of induced pluripotent stem cells to address questions about the mechanisms of evolutionary adaptation in humans.

Anna L Gloyn (she/her)

Anna Gloyn is currently Professor of Pediatrics and Genetics at Stanford University. She trained at the Universities of Oxford, Exeter and Pennsylvania. The consistent focus of her research has been using naturally occurring mutations in humans as tools to identify critical regulatory pathways and insights into normal physiology and to translate this information into improvements in clinical care. (Full: Anna Gloyn is currently Professor of Pediatrics and by Courtesy Genetics at Stanford University. The consistent focus of her research has...more

Matthew Hurles (he/him)

Matthew Hurles is Director of the Wellcome Sanger Institute and leads a research group focused on deciphering the genetic causes of severe developmental disorders, and understanding how DNA mutates as it is passed from generation to generation.

Jonathan Mill

My research focuses on understanding both the causes and consequences of molecular variation in the human brain and the role this plays in dementia and neuropsychiatric disorders. My group is interested in the dynamic genomic processes occurring in the human brain during development and aging, exploring interactions between the epigenome, environment and DNA sequence variation. Using cutting-edge genomics methods, we aim to undertake an integrated genetic-epigenetic approach to disease, incorporating genetic, transcriptional and epigenomic variation. We led the first large-scale...more

JT Neal (he/him)

Dr. James (JT) Neal is an Institute Scientist and Director of Systems Genomics at the Broad Institute of MIT & Harvard in the Metabolism Program and the NNF Center for the Genomic Mechanisms of Disease. His lab develops and applies novel technologies for genome editing as well as massively parallel single-cell imaging and transcriptomics approaches for studying the effects of genetic variation in cancer, diabetes, and other diseases.

Frederick (Fritz) Roth

Roth trained in physics and biology at UC Berkeley and Harvard. He chairs the Department of Computational and Systems Biology at the University of Pittsburgh. His group is combining experimental and computational methods to systematically map the context-dependent impacts of human sequence variation.

Alan Rubin (he/him)

Dr. Rubin is a computational biologist at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. Alan’s work focuses on developing new tools and approaches to analyze and interpret high-throughput genomics data.

Lea Starita (she/her)

Dr. Starita is an Assistant Professor. in the Department of Genome Sciences at the University of Washington and the Co-director of Brotman Baty Advanced Technology Lab. She earned her Ph.D. from Harvard Medical School before coming to the University of Washington to train in functional genomics with Stan Fields and Jay Shendure.


Previous Executive Committee Members

Gladys Fongong (she/her)

Program Operations Specialist

William C Hahn (he/him)

Executive Committee Member (Broad Institute)

Beth Lowry (she/her)

Administrative Specialist 

Debora Marks (she/her)

Executive Committee Member (Harvard Medical School)


Administrative Support

Alex Hopkins (he/him)

Program Operations Specialist 

hopkins3@uw.edu

Lara Muffley (she/her)

Director of Program Operations

muffley@uw.edu

AVE Workstream Chairs

Analysis, Modelling and Prediction (AMP)

Joseph Marsh

Dr. Marsh leads a group in the MRC Human Genetics Unit, University of Edinburgh. His work seeks to understand the molecular mechanisms by which mutations affect proteins and thereby cause disease, combining computational modelling and high-throughput experiments to improve the interpretation of protein-coding variants.


Clinical Variant Interpretation (CVI)

Lea Starita (she/her)

Dr. Starita is an Assistant Professor. in the Department of Genome Sciences at the University of Washington and the Co-director of Brotman Baty Advanced Technology Lab. She earned her Ph.D. from Harvard Medical School before coming to the University of Washington to train in functional genomics with Stan Fields and Jay Shendure.

Clare Turnbull

Professor Clare Turnbull is a Professor of Translational Cancer Genetics at the Institute for Cancer Research, London, and a NHS Consultant in Clinical Cancer Genetics at The Royal Marsden NHS Foundation Trust and Consultant in Public Health Medicine for NHS Digital. Her work focuses on implementation of effective, evidenced cancer susceptibility genetic testing in the diagnostic setting, one part of which is ensuring accuracy and consistency on classification of variants.


Data Coordination and Dissemination (DCD)

Julia Foreman

Dr. Julia Foreman is Project Leader for DECIPHER at the European Molecular Biology Laboratory, European Bioinformatics Institute, in the UK. DECIPHER is an international web-based platform that shares rare disease phenotype-linked variant data. Julia is committed to open data, in particular sharing data to facilitate the transfer of research knowledge into the clinical arena, to facilitate discovery and enable diagnosis.

Alan Rubin (he/him)

Dr. Rubin is a computational biologist at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. Alan’s work focuses on developing new tools and approaches to analyze and interpret high-throughput genomics data.


Experimental Technology and Standards (ETS)

Andrew Glazer

Dr. Glazer is an Assistant Professor at Vanderbilt University Medical Center. He earned a PhD in genetics from the University of California-Berkeley and did postdoctoral research at Vanderbilt. Andrew's lab uses high-throughput functional assays to study variants in ion channel genes, with a focus on arrhythmia syndromes.

Alex Nguyễn Ba

Dr. Nguyen Ba is an Assistant Professor at the University of Toronto (UofT). He earned his PhD in computational biology at UofT and did his postdoctoral training on high-throughput genetics and synthetic biology with Michael Desai at Harvard University. His lab focuses on fundamental questions on the genotype-phenotype map and on humanized yeast models for variant effect mapping.

Variant Effects Seminar Series Organizing Committee

Priyanka Bajaj (she/her)

Priyanka is a postdoctoral fellow, co-mentored by Prof. James Fraser and Dr. Willow Coyote-Maestas at UCSF. She is interested in integrating deep sequencing with machine learning techniques to determine the structural basis of fusion protein-driven oncogenesis. She did her Ph.D. at Indian Institute of Science under the supervision of Prof. Raghavan Vardarajan. She developed high-throughput screens using deep mutational scanning to study the effects of mutations on protein activity, stability, and co-translational folding.

Ohanna Bezerra (she/her)

Ohanna is a CANSSI STAGE postdoctoral researcher at the University of Toronto in the Dalla Lana School of Public Health. She applies statistical methods in DNA methylation and whole genome sequencing data to understand the epidemiological, genetic, and epigenetic determinants of complex diseases. A molecular biologist by training, Ohanna received a master’s and PhD degree in Genetic Epidemiology from the Oswaldo Cruz Institution in Brazil, where she studied genetic susceptibility of infectious diseases in admixed population. For her bachelor’s degree,...more

Social Links

@ohannaclb

Matteo Cagiada (he/him)

Matteo is a Novo Nordisk Foundation Postdoctoral Fellow at the University of Oxford / University of Copenhagen, where he is supervised by Prof. Charlotte Deane and Prof. Philip Biggin. Matteo's current research interests are in immunoinformatics, computational structural biology and variant effect prediction. During his Ph.D. in Biology, supervised by Prof. Kresten Lindorff-Larsen at the University of Copenhagen, Matteo worked on understanding the mechanisms behind loss-of-function and built predictors to classify variants based on their effects on proteins.

Ziyi Dai (she/her)

Ziyi is a PhD student in the Department of Molecular Genetics at the University of Toronto, under the supervision of Dr. Gregory Costain. Her doctoral research focuses on leveraging large-scale genome sequencing data to investigate variant effects and their transmission within human populations. In addition to her primary research, Ziyi actively participates in workgroups dedicated to newborn sequencing and engages in scientific outreach initiatives.

Mariano Martín

Mariano is a postdoctoral researcher at the Institute for Bioengineering of Catalonia (IBEC) in the “Protein phase transitions in health and disease” lab, under the supervision of Drs. Benedetta Bolognesi and Ben Lehner. Mariano aims to understand how amino acids changes affects amyloid aggregation using massively parallel reporter assays. He received his Ph.D. from National University of Cordoba, Argentina, where he studied how variants in sodium iodide symporter (NIS) may cause congenital hypothyroidism, supervised by Dr. Juan Pablo Nicola. As...more

Jingyou Rao (she/her)

Jingyou is a PhD student in the Department of Computer Science at the University of California, Los Angeles, where she conducts research under the guidance of Dr. Harold Pimentel. Her work focuses on developing rigorous statistical inference frameworks tailored to diverse types of deep mutational scanning data. Additionally, she is informally co-mentored by Dr. Willow Coyote-Maestas at the University of California, San Francisco, where she enjoys bridging computational analysis with experimental biochemistry and biophysics.

Adelaide Tovar (she/they)

Adelaide is an NHGRI MOSAIC K99/R00 postdoctoral fellow at the University of Michigan where she works with Drs. Stephen Parker and Jacob Kitzman. She completed her PhD training in statistical genetics and genomics to study gene-environment interactions. Currently, she leads a multi-institution effort to characterize all noncoding variants associated with type 2 diabetes across cell types and stimulation states using massively parallel reporter assays. ​​With the support of her K99/R00 award, she is building a research program to study broad...more

Previous Variant Effect Seminar Series Committee Members

Diego Calderon

Organizing Committee (University of Washington)

Steven Erwood

Organizing Committee (Broad Institute of MIT and Harvard))

Yann Ilboudo

Organizing Committee (McGill University)

Mireia Seuma

Organizing Committee (Benedetta Bolognesi Lab, Institute for Bioengineering of Catalunya (IBEC), Barcelona)

Adrine de Souza

Organizing Committee (Roth Lab, University of Toronto)